General
Release from Glaxo Smith Kline (BIOC.CA) Concerning the Board of Directors & the Executive Managers
AI Summary
AI-powered disclosure summary — Coming soon 🔜
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
Release from the company concerning the Board of Directors & the Executive Managers.
Release from the Company (571 KB)
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
Release from the company concerning the Board of Directors & the Executive Managers.
Release from the Company (571 KB)